VivoSeq
Other

Hyperhidrosis

24

Pipeline Programs↗

0

Active Trials↗

10

Companies Involved↗

Hyperhidrosis is an emerging landscape with 24 programs across 10 companies. The most active players are Astellas, AbbVie, Atacama Therapeutics. 2 therapies are approved with 4 more in late-stage development.

Intelligence

Pipeline Metrics

Competitive Density

48/100

Pipeline Velocity

0/100

Mech. Concentration

33/100

Completion Rate

88/100

Attrition Rate

11/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Astellas logo

Astellas

1 program

Phase 1AbbVie logo

AbbVie

2 programs

Phase 2A

Atacama Therapeutics

1 program

Phase 2R

Revance Therapeutics, Inc.

1 program

Phase 2W

Watson Pharmaceuticals

1 program

Phase 2Novartis logo

Novartis

1 program

Phase 2

Pipeline

Programs by Phase

Analysis

Trial Status

54

clinical trials

Completed46 · 85%
Terminated4 · 7%
Withdrawn2 · 4%
Unknown status2 · 4%

Clinical Trials

Trial Activity

54 trials

A Study Using Botulinum Toxin Type A in Patients With Axillary Hyperhidrosis
Completed·AbbVie logoAbbVie·Phase 4·NCT00168480·424 enrolled
Qbrexza Cloths for Hyperhidrosis of Amputation Sites
Completed·UUniversity of Utah·Phase 2·NCT04924036·13 enrolled
Evaluate the Efficacy and Safety of MEDITOXIN in Treatment of Primary Axillary Hyperhidrosis
Completed·MMedy-Tox·Phase 3·NCT03760198·220 enrolled
Use of Oxybutynin for Treating Hyperhidrosis: A Placebo-control Study
Completed·UUniversity of Sao Paulo·Phase 4·NCT01310712·50 enrolled
Use of Oxybutynin to Treat Axillary Hyperhidrosis
Completed·GGrupo de Cirurgia Vascular·N/A·NCT01118429·100 enrolled
Long Term Results of the Use of Oxybutynin for the Treatment of Hyperhidrosis
Completed·HHospital Israelita Albert Einstein·N/A·NCT01956591·1,100 enrolled
Hyperhidrosis, Developing a Treatment Approach Aims 1 & 2
Completed·UUniversity of Utah·Phase 1·NCT03416348·95 enrolled
Botox and Suction-Curettage for Treatment of Excessive Underarm Sweating (Axillary Hyperhidrosis)
Completed·NNorthwestern University·N/A·NCT01274611·20 enrolled
A Safety, Tolerability and Preliminary Efficacy Study of BBI-4000 Gel in Subjects With Palmar Hyperhidrosis
Completed·BBotanix Pharmaceuticals·Phase 2·NCT02682238·50 enrolled
A Dose-Ranging Study of the Effect of Glycopyrrolate in Subjects With Axillary Hyperhidrosis
Completed·—·Phase 2·NCT02016885·198 enrolled
A Safety, Tolerability and Preliminary Efficacy Study of BBI-4000 in Subjects With Axillary Hyperhidrosis
Completed·BBotanix Pharmaceuticals·Phase 1·NCT02058264·18 enrolled
Safety and Efficacy Study of Sofpironium Bromide in Subjects With Axillary Hyperhidrosis (BBI-4000-CL-302)
Completed·BBotanix Pharmaceuticals·Phase 3·NCT03948646·351 enrolled
Clinical Trial to Evaluate ANT-1403 in the Treatment of Primary Axillary Hyperhidrosis
Completed·AAnterios Inc.·Phase 2·NCT01799824·52 enrolled
A Study Using Botulinum Toxin Type A in Adolescents With Axillary Hyperhidrosis
Completed·AbbVie logoAbbVie·Phase 4·NCT00168415·144 enrolled
A Study to Compare Oxybutynin to a Placebo in Women and the Effect on Plantar Hyperhidrosis
Completed·FFederal University of São Paulo·Phase 2·NCT01328015·32 enrolled
Page 1 of 4

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)